DDIT3 and rheumatoid arthritis: These results suggest that CHOP could serve as a therapeutic gene target of RA, and that the efficacy of DHA would be the most significant when applied to cells that show both abnormal proliferation and pro-inflammatory function, such as RA-FLS cells.